Emerald Mutual Fund Advisers Trust Lantheus Holdings, Inc. Transaction History

Emerald Mutual Fund Advisers Trust

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$55.6 - $77.89 $10 Million - $14 Million	-180,130 Reduced 66.78%	89,610 $5.56 Million
Q3 2023 Oct 26, 2023	BUY	$60.27 - $90.75 $1.17 Million - $1.76 Million	19,395 Added 7.75%	269,740 $18.7 Million
Q2 2023 Aug 10, 2023	SELL	$82.41 - $99.65 $14.2 Million - $17.1 Million	-172,070 Reduced 40.73%	250,345 $21 Million
Q1 2023 May 04, 2023	BUY	$47.76 - $82.86 $3.99 Million - $6.93 Million	83,614 Added 24.68%	422,415 $34.9 Million
Q4 2022 Feb 03, 2023	BUY	$48.76 - $77.67 $1.73 Million - $2.76 Million	35,548 Added 11.72%	338,801 $17.3 Million
Q3 2022 Oct 25, 2022	BUY	$61.42 - $86.29 $73,826 - $103,720	1,202 Added 0.4%	303,253 $21.3 Million
Q2 2022 Jul 29, 2022	BUY	$55.54 - $72.65 $16.8 Million - $21.9 Million	302,051 New	302,051 $19.9 Million
Q4 2020 Jan 29, 2021	SELL	$10.75 - $14.91 $13,953 - $19,353	-1,298 Closed	0 $0
Q3 2020 Oct 28, 2020	SELL	$11.98 - $16.34 $3,785 - $5,163	-316 Reduced 19.58%	1,298 $16,000
Q2 2020 Jul 28, 2020	BUY	$10.34 - $15.51 $16,688 - $25,033	1,614 New	1,614 $23,000

538

68.4M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.7B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.